Pharmaceutical - Markets & Marketing, Sanofi Pasteur


Popular Filters

News briefs: Lexicon's IBS drug; Sanofi Pasteur launch in Thailand; Tranzyme drops TZP-102


US drug developer Lexicon Pharmaceuticals (Nasdaq: LXRX) saw its shares leap 9.1% to $2.04 in premarket…

DiabetesGastro-intestinalsLexicon PharmaceuticalsLX1033Markets & MarketingPharmaceuticalRegulationResearchSanofiSanofi PasteurTranzymeTZP-102Vaccines

Australian launch for Sanofi Pasteur's Imojev, first single-dose vaccine against Japanese encephalitis


Sanofi Pasteur, the vaccines division of Sanofi (Euronext: SAN) has launched its Imojev vaccine against…

Asia-PacificImojevMarkets & MarketingPharmaceuticalSanofiSanofi PasteurVaccines

CREW files motion to quash Sanofi Pasteur subpoena


Washington DC, USA-based non-profit legal watchdog group Citizens for Responsibility and Ethics (CREW)…

LegalMarkets & MarketingNorth AmericaPharmaceuticalSanofiSanofi PasteurVaccines

Sanofi Pasteur starts shipping Fluzone in USA for 2012-2013 flu season


The first lots of Fluzone vaccine have began shipping to US health care providers following Food and…

Anti-viralsFluzoneMarkets & MarketingNorth AmericaPharmaceuticalSanofiSanofi PasteurVaccines

US consumer groups call on FTC to investigate anti-competitive practices of vaccine makers


In the USA, Citizens for Responsibility and Ethics in Washington (CREW), the National Legislative Association…

CervarixGardasilMarkets & MarketingMerck & CoNorth AmericaPharmaceuticalPricingSanofiSanofi PasteurVaccines

Back to top